Citius Oncology Inc. (CTOR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Citius Oncology Inc.

    NASDAQ: CTOR · Real-Time Price · USD
    1.91
    0.02 (1.06%)
    At close: Sep 12, 2025, 3:59 PM
    1.90
    -0.52%
    After-hours: Sep 12, 2025, 06:16 PM EDT

    Citius Oncology Income Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -20.57M -12.12M -4.86M n/a
    Interest Income
    		 n/a 3.43M 493.02K n/a
    Pretax Income
    		 -20.57M -12.12M -4.86M -10.11K
    Net Income
    		 -21.15M -12.7M -5.43M -10.11K
    Selling & General & Admin
    		 15.65M 7.88M 1.43M n/a
    Research & Development
    		 4.92M 4.24M 3.43M n/a
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 20.57M 12.12M 4.86M n/a
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 20.57M 12.12M 4.86M n/a
    Income Tax Expense
    		 576K 576K 576K n/a
    Shares Outstanding (Basic)
    		 71.55M 89.48M 90.16M 81.4M
    Shares Outstanding (Diluted)
    		 71.55M 89.48M 90.16M 81.4M
    EPS (Basic)
    		 -0.3 -0.19 -0.08 -0.00
    EPS (Diluted)
    		 -0.3 -0.19 -0.08 -0.00
    EBITDA
    		 -20.57M -12.12M -4.86M -10.11K
    EBIT
    		 -20.57M -12.12M -4.86M -10.11K
    Depreciation & Amortization
    		 n/a n/a n/a n/a

    Add to Watchlist